Price$67.36-14.67 (-17.89%)
2026-03-042026-06-05
News · 26 weeks52+20%
2025-12-142026-06-07
Mix2390d
- Insider9(39%)
- Other6(26%)
- SEC Filings4(17%)
- Earnings2(9%)
- Leadership1(4%)
- Analyst1(4%)
Latest news
25 items- SECSEC Form 10-Q filed by The Cooper Companies Inc.10-Q - COOPER COMPANIES, INC. (0000711404) (Filer)
- ANALYSTNeedham reiterated coverage on Cooper with a new price targetNeedham reiterated coverage of Cooper with a rating of Buy and set a new price target of $86.00 from $101.00 previously
- SECSEC Form 8-K filed by The Cooper Companies Inc.8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
- PRCooperCompanies Announces Second Quarter 2026 ResultsSAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026. Second quarter 2026 revenue of $1.082 billion, up 8%, or up 5% organically, from last year's second quarter.Second quarter 2026 GAAP diluted earnings per share (EPS) of $(0.40), down $0.84 from last year's second quarter driven by a litigation-related charge to resolve outstanding claims associated with a December 2023 voluntary product recall at CooperSurgical.Second quarter 2026 Non-GAAP diluted EPS of $1.21, up $0.25 or 26% from last year's second quarter. See "Reconciliation of
- SECSEC Form SD filed by The Cooper Companies Inc.SD - COOPER COMPANIES, INC. (0000711404) (Filer)
- PRCooperVision Names Muru Annamalai as President, Asia-PacificExperienced Global Healthcare Leader to Guide Growth Across the RegionSINGAPORE, May 29, 2026 /PRNewswire/ -- CooperVision has named Muru Annamalai as President, Asia-Pacific, effective June 1, 2026. He brings more than two decades of global leadership experience across the pharmaceutical and healthcare sectors, with extensive expertise leading commercial organizations and driving growth across Asia-Pacific, Latin America, and other global markets. His appointment reflects CooperVision's broader investment in guiding the company's next phase of growth across one of its most dynamic and strategically important regions.
- SECThe Cooper Companies Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
- PRCooperCompanies Appoints Paul Keel to its Board of DirectorsSAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board. "We are delighted to welcome Paul to our Board as a new Director," said Colleen Jay, Chair of the Board of CooperCompanies. "His experience as a CEO in the medical device sector, along with a successful track record of leading complex global operations, will be a significant asset as Cooper continues to execute its strategy and create long-term value for patient
- PRCooperCompanies Announces Release Date for Second Quarter 2026SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com About CooperCompanies CooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beauti
- INSIDERSEC Form 4 filed by Rosebrough Walter M Jr4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- PRCooperVision Partners with Canadian Olympic Speed Skater Valérie Maltais on Her Continued Pursuit of Excellence on the World StageRICHMOND HILL, ON, April 16, 2026 /CNW/ - CooperVision Canada is proud to announce a new partnership with Valérie Maltais, one of Canada's most decorated Olympic speed skaters, as she continues to pursue excellence both on the ice and in her academic studies. As she trains toward the next major international competitions, Maltais relies on MyDay Energys® contact lenses, which deliver premium optics shown to improve vision and comfort*1,2. Maltais' career is defined by speed, strategy, and precision. A five‑time Olympian and multi‑medalist, she competes in an environment where th
- PRCooperVision Launches MADE BETTER™ Promise Beginning with MyDay® Contact Lenses*¹New sustainability platform reflects company's commitment to responsible sourcing, moreefficient manufacturing, and offsetting a portion of plastic footprint*†1ROCHESTER, N.Y., April 9, 2026 /PRNewswire/ -- CooperVision announced today the launch of its MADE BETTER™ Promise—a new global sustainability platform focused on smarter, more sustainable choices.*†1 Built on years of CooperVision innovation in sustainability, MADE BETTER™ Promise is woven throughout the life of participating products, beginning with the MyDay® daily disposable family of contact lenses.*†1 COO), is one of the world's leading manufacturers of contact l
- PRTelix Strengthens Board with Additional Director AppointmentsMELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, as part of Board expansion and succession planning: Maria Rivas, MD is an experienced public company board director and S&P 100 senior pharmaceutical executive with more than 25 years' experience in late-stage clinical development, commercialization and governance leadership. Dr. Rivas currently serves on the board of directors of The Cooper Companies, Inc. (NASDAQ:COO), a medical technology company, and also served as an independent director for Medidata
- SECThe Cooper Companies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
- INSIDERSEC Form 4 filed by Weiss Robert S4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Rivas Maria4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Jay Colleen4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Carbone Barbara4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Rosebrough Walter M Jr4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Madden Teresa S4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Lucchese Cynthia L4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 4 filed by Kurzius Lawrence Erik4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by The Cooper Companies Inc.SCHEDULE 13G/A - COOPER COMPANIES, INC. (0000711404) (Subject)
- SECSEC Form 10-Q filed by The Cooper Companies Inc.10-Q - COOPER COMPANIES, INC. (0000711404) (Filer)
- SECSEC Form 8-K filed by The Cooper Companies Inc.8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
COO FAQ
6 questionsWhat does The Cooper Companies Inc. do?
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for...Where does COO stock trade?
The Cooper Companies Inc. (COO) is listed on NYSE.What sector and industry is COO in?
The Cooper Companies Inc. operates in the Health Care sector, Ophthalmic Goods industry.What are analysts saying about COO?
The Cooper Companies Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy on 2026-06-05.What companies are similar to COO?
Notable peers in the same industry include ALC (Alcon Inc.), BLCO (Bausch + Lomb Corporation), WRBY (Warby Parker Inc.), STAA (STAAR Surgical Company), EYE (National Vision Holdings Inc.). Compare COO side-by-side with any of them on Quantisnow.How can I track COO on Quantisnow?
Quantisnow aggregates The Cooper Companies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COO to receive live email and push alerts on every new disclosure.